MASTERFLEX
Earnings Call Presentation 9M/2021
November 10, 2021
3
Agenda
Overview
Figures 9M/2021
Outlook
Appendix
Overview | Figures | Outlook | Appendix | 3 |
Overview
Overview | Figures | Outlook | Appendix | 4 |
Highlights 9-month period 2021
- Growth in the 9-month period above plan.
- High order backlog compared to 12/31/2020 (EUR 9.4 million) significantly increased to around EUR 15.4 million as of 09/30/2021 - underpins revenue and earnings targets.
- Stable revenue development: Group revenue at EUR 59.6 million, 6.8% above previous year's level; Q3 2021 revenue and earnings above pre-Coronalevel of 2019.
- Group operating EBIT at EUR 5.8 million, 64.7% above the previous year's period (EUR 3.5 million).
- Mid-termearnings target "Double Digit" almost achieved with EBIT-margin of 9,7% (9M/2020: 6.3%).
- Stable liquidity situation despite strategic working capital build-up - high cash balance at EUR 8.1 million.
- High demand in the classic industrial sectors (mechanical engineering, automotive) - catch-up effects as well as retooling to more sustainable manufacturing processes.
- Medical technology impacted by COVID-19 specialWettbewerbsstärkeneconomic situation and postponed surgery - nevertheless consistent expansion of the product portfolio of medical hose solutions in line with a long-term focus.
Overview | Figures | Outlook | Appendix | 5 |
Figures 9-month period 2021
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Masterflex SE published this content on 10 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 November 2021 06:34:04 UTC.